Pacira Pharmaceuticals buy StockNews.com
Start price
05.08.23
/
50%
€35.80
Target price
05.08.24
-
Performance (%)
-20.67%
Price
22.05.24
€28.00
Summary
This prediction is currently active. The price of Pacira Pharmaceuticals has decreased since the start of the prediction. Compared to the start price this results in a performance of -20.67%. This prediction currently runs until 05.08.24. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Pacira Pharmaceuticals | 2.190% | 2.190% |
iShares Core DAX® | -1.347% | 3.576% |
iShares Nasdaq 100 | 1.169% | 7.020% |
iShares Nikkei 225® | -0.327% | -0.673% |
iShares S&P 500 | 0.510% | 4.445% |
Comments by StockNews_com for this prediction
In the thread Pacira Pharmaceuticals diskutieren
Pacira BioSciences, Inc. (NASDAQ: PCRX) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for PCRX provided by MarketBeat